Destroy Smallpox Stocks

About the pros and cons of destroying the world's last remaining stocks of smallpox virus [K.Y. Kreeger, The Scientist, Nov. 14, 1994, page 1]: It is amusing that the advocates of preserving the virus imply that only virologists can appreciate the value of saving it. I submit that the issue of the likelihood that terrorists or criminals could obtain the virus is one that falls into the province of historians, not virologists. The deliberate release of the smallpox virus is likely to be devast

Written byRichard Luduena
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The deliberate release of the smallpox virus is likely to be devastating. How secure is the virus, really? Could armed terrorists break into a facility and steal the virus? Could whoever looks after it be threatened, blackmailed, or bribed into releasing it into criminal hands? Could a new government come to power and choose to use the virus as an agent of biological warfare?

Of course, these scenarios are extremely unlikely, but they don't have to be probable; for a catastrophe, release needs to happen only once. Are those who would claim that these scenarios could not happen now able to predict that they could not occur 10 or 100 years from now? I doubt that even a historian could predict this, let alone a virologist.

The analogy of nuclear weapons is perhaps relevant. Since the end of the Cold War, the bombs are in the handsof the Ukraine, Belarus, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies